Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Man-made antibodies.

G Winter1, C Milstein

  • 1MRC Laboratory of Molecular Biology, Cambridge, UK.

Nature
|January 24, 1991
PubMed
Summary
This summary is machine-generated.

Gene technology allows genetic engineering of monoclonal antibodies for new properties. Future applications may involve bacterial expression of variable domain genes, potentially replacing animal immunization for antibody fragment production.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hybrid hybridomas and the production of bi-specific monoclonal antibodies.

Immunology today·2014
Same author

SPINE workshop on automated X-ray analysis: a progress report.

Acta crystallographica. Section D, Biological crystallography·2006
Same author

Engineering aggregation-resistant proteins by directed evolution.

Protein engineering, design & selection : PEDS·2006
Same author

Continuous cultures of fused cells secreting antibody of predefined specificity. 1975.

Journal of immunology (Baltimore, Md. : 1950)·2005
Same author

Automation of the collection and processing of X-ray diffraction data -- a generic approach.

Acta crystallographica. Section D, Biological crystallography·2002
Same author

[Design Check. A screening method to assess physical stress].

Der Orthopade·2002
Same journal

Incoming US science academy chief vows to 'double down' on research.

Nature·2026
Same journal

Author Correction: Synthesis of enantioenriched atropisomers by biocatalytic deracemization.

Nature·2026
Same journal

Electrodeposited self-assembled molecules for perovskite photovoltaics.

Nature·2026
Same journal

Neutrino's nursery found: the 'Shadow Blaster'.

Nature·2026
Same journal

Dementia risk in middle-aged people linked to a blood protein.

Nature·2026
Same journal

Daily briefing: What's really happening with trust in science.

Nature·2026
See all related articles

Area of Science:

  • Biotechnology
  • Molecular Biology
  • Immunology

Background:

  • Monoclonal antibodies (mAbs) are crucial in diagnostics and therapeutics.
  • Genetic engineering offers novel ways to modify mAb properties.
  • Current production methods for antibody fragments often rely on animal immunization.

Purpose of the Study:

  • To explore the potential of gene technology for producing antigen-binding fragments.
  • To investigate the feasibility of using 'in vitro' gene repertoires.
  • To assess if this approach can eliminate the need for animal immunization.

Main Methods:

  • Genetic engineering of monoclonal antibodies.
  • Exploiting repertoires of variable domain genes.
  • Bacterial expression systems for antibody fragment production.

Related Experiment Videos

Main Results:

  • Monoclonal antibodies can be genetically engineered with new functionalities.
  • Gene technology enables the use of variable domain gene repertoires.
  • Bacterial expression is a viable route for producing antibody fragments.

Conclusions:

  • Gene technology holds significant promise for antibody engineering.
  • In vitro' repertoires could streamline antibody fragment production.
  • This approach may reduce or eliminate reliance on animal immunization in the future.